GEFTINAT 250 — EXCLUSIVE IN UKRAINE NEW GENERATION DRUG USED FOR TREATMENT OF REFRACTORY NON-SMALL CELL LUNG CANCER

This paper offers the short review on chemotherapy schemes for treatment of non-small cell lung carcinoma (NSLC). Also, the data on randomized studies of geftinat usage for treatment of NSLC is presented.



No comments » Add comment